About this OCP
We acknowledge the Traditional Owners of Country throughout Australia and their continuing connection to the land, sea and community. We pay our respects to them and their cultures and to Elders past, present and emerging.
This work is available from the Leukaemia Foundation website and from the Cancer Council website.
This edition published in October 2021. ISBN: 978-0-6453299-4-0
Leukaemia Foundation and Australian Government Department of Health 2021, Optimal care pathway for people with chronic lymphocytic leukaemia, 1st edn, Leukaemia Foundation of Australia.
Enquiries about this publication can be sent to bloodcancerpartnerships@leukaemia.org.au.
Our thanks to the following health professionals, consumer representatives, stakeholders and organisations consulted in developing this optimal care pathway.
Professor John Seymour AM (Chair), Haematologist, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne
Dr Carolyn Ee, General Practitioner, Western Sydney University, Primary Care Collaborative Cancer Clinical Trials Group
Professor Wendy Erber, Haematologist, PathWest Laboratory Medicine, Professor of Pathology and Laboratory Medicine, University of Western Australia
Associate Professor Stephen Fuller, Haematologist, University of Sydney Nepean Clinical School
Dr Georgina Hodges, Haematologist, Andrew Love Cancer Centre
Sharon Millman, Chief Executive Officer, Lymphoma Australia
Lisa Oakman, Lymphoma Care Nurse
Deborah Henderson, Consumer Representative
Dr Nienke Zomerdijk, Research Fellow Psycho- Oncology, University of Melbourne, Victorian Comprehensive Cancer Centre Alliance
Dr Gavin Cull, Haematologist, Sir Charles Gairdner Hospital, PathWest Laboratory Medicine and University of Western Australia
Associate Professor Bryone Kuss, Haematologist, Flinders Medical Centre
Dr Hui-Peng Lee, Haematologist,
Flinders Medical Centre, Haematology Society of Australia and New Zealand
Professor Stephen Opat, Haematologist, Monash Health, Clinical Professor Monash University, Australasian Lymphoma and Related Disease Registry
Professor Constantine S Tam, Haematologist, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, Professor of Haematology, University of Melbourne
Australian Capital Territory Health
Allied Health Professions Australia
Australian and New Zealand Children’s Haematology/Oncology Group
Australia and New Zealand Transplant and Cellular Therapies
Australasian Association of Nuclear Medicine Specialists
Australasian College of Emergency Medicine Australasian Leukaemia & Lymphoma Group
Australian and New Zealand Society of Palliative Care
Australian College of Nursing
Australian College of Rural and Remote Medicine Australian Government Department of Health
and Ageing
Australian Medical Association Beyond Blue
Cancer Australia
Cancer Council of Australia Cancer Council Victoria Cancer Institute NSW
Cancer Nurses Society of Australia Canteen
Clinical Oncology Society of Australia Haematology Society of Australia & New Zealand Launceston General Hospital
Leukaemia Foundation Lymphoma Australia
Medical Oncology Group of Australia Myeloma Australia
Northern Territory Department of Health Palliative Care Australia
Private Cancer Physicians of Australia Queensland Health
Rare Cancers Australia Redkite
Royal Australasian College of Physicians
Royal Australian and New Zealand College of Radiologists
Royal College of Pathologists of Australasia South Australia Health
Tasmanian Department of Health and Human Services
The Royal Australian College of General Practitioners
Victorian Department of Health
Western Australia Cancer and Palliative Care Network
Associate Professor Peter Mollee (Chair), Haematologist Princess Alexandra Hospital, Australasian Leukaemia and Lymphoma Group, Associate Professor, University of Queensland
Dr Caroline M Bateman, Paediatric Haematologist and Oncologist, Cancer Centre for Children, The Children’s Hospital at Westmead
Julia Brancato, Optimal Care Pathways Project Coordinator, Cancer Council Victoria
Dr Peter Diamond, Project Secretariat, Leukaemia Foundation
Associate Professor Michael Dickinson, Haematologist, Lymphoma Australia, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne
Associate Professor Anoop Enjeti, Haematologist, John Hunter Hospital, Senior Staff Haematologist, Calvary Mater Hospital, Conjoint Associate Professor, University of Newcastle
Emily Forrest, Project Secretariat, Leukaemia Foundation
Fiona Haigh, Project Secretariat, Leukaemia Foundation
Deborah Henderson, Consumer Representative
Professor Tim Hughes, Haematologist, South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, Royal Adelaide Hospital
Professor Steven Lane, Haematologist, Royal Brisbane and Women’s Hospital, QIMR
Berghofer Medical Research Institute, University of Queensland
Caroline Nehill, Director National Cancer Control, Cancer Australia
Professor H. Miles Prince AM, Haematologist, Epworth Healthcare and Haematologist, Peter MacCallum Cancer Centre
Professor Hang Quach, Haematologist, University of Melbourne, St. Vincent’s Hospital Melbourne
Catriona Rafael, Project Secretariat, Leukaemia Foundation
Professor Andrew Roberts AM, Haematologist and Bone Marrow Transplant Physician, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, University of Melbourne, Walter and Eliza Hall Institute
Professor John Seymour AM, Haematologist, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne
Delaine Smith, Chief Executive Officer, Australasian Leukaemia and Lymphoma Group
Professor Judith Trotman, Haematologist, Concord Repatriation General Hospital, University of Sydney
Megan Varlow, Director Cancer Control Policy, Cancer Council Australia
Dr Nicole Wong Doo, Haematologist, Concord Repatriation and General Hospital, University of Sydney
Our thanks also to the Blood Cancer Taskforce, which recommended the development of optimal care pathways for all the major blood cancer subtypes as part of the National Strategic Action Plan for Blood Cancer (2020). The National Action Plan was commissioned by the Federal Government and developed by the Blood Cancer Taskforce, with support from the Leukaemia Foundation.